Tarsa Therapeutics
Latest round
- Series B
Last raised
- May 2014
Total raised
- $46M
Investors
- 4
About Tarsa Therapeutics
Founded in 2009 in Philadelphia, US, Tarsa Therapeutics specializes in therapies for postmenopausal osteoporosis.00 mn from Oxford Finance Corporation and Square 1 Bank.Tarsa Therapeutics develops TBRIA™, an oral formulation of calcitonin specifically designed for women post-menopause. This product aims to provide an effective treatment option for those for whom alternative therapies are unsuitable.Tarsa Therapeutics generates revenue through strategic partnerships and licensing agreements, particularly with R-Pharm JSC, which has acquired rights for further clinical development and regulatory submissions for TBRIA. The company is focused on expanding TBRIA's market reach, particularly targeting regions with high rates of postmenopausal osteoporosis. Future initiatives include upcoming new products that build on the existing portfolio, although specific release dates are yet to be disclosed.
Who invested in Tarsa Therapeutics
4 investors across 4 rounds
See all investors in Tarsa Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Tarsa Therapeutics
Who invested in Tarsa Therapeutics?
Tarsa Therapeutics has 4 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tarsa Therapeutics raised?
Tarsa Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Tarsa Therapeutics last raise money?
Tarsa Therapeutics's most recent round on record is a Series B, in May 2014.
What does Tarsa Therapeutics do?
Founded in 2009 in Philadelphia, US, Tarsa Therapeutics specializes in therapies for postmenopausal osteoporosis.
Where is Tarsa Therapeutics headquartered?
Tarsa Therapeutics is headquartered in Philadelphia, US.
Which VCs invest in companies like Tarsa Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Tarsa Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Tarsa Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.